Concepedia

Samanta Salvi

SS

24

Publications

1.6K

Citations

17

H-Index

2008

Active since

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Ospedale G.B. Morgagni - L.Pierantoni

Institute of Cancer Research

University of Trento

Samanta Salvi is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, pathology, and urology.

ORCID

Top concepts

Publications per year

2008–2021

24

Publications

24

Plasma <i>AR</i> and abiraterone-resistant prostate cancer

Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca et al. · Science Translational Medicine · 2015 · 431 citations · Full text

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study

Vincenza Conteduca, Daniel Wetterskog, Mansour T. A. Sharabiani et al. · Annals of Oncology · 2017 · 263 citations · Full text

Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone

Samanta Salvi, Valentina Casadio, Vincenza Conteduca et al. · British Journal of Cancer · 2015 · 123 citations · Full text

Genome-wide plasma DNA methylation features of metastatic prostate cancer

Anjui Wu, Paolo Cremaschi, Daniel Wetterskog et al. · Journal of Clinical Investigation · 2020 · 98 citations · Full text

<i>GSTP1</i>Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications

Filippo Martignano, Giorgia Gurioli, Samanta Salvi et al. · Disease Markers · 2016 · 95 citations · Full text

Rows per page

1–5 of 24